Published date: 13 May 2022

Last edited date: 13 May 2022

This notice was replaced on 13 May 2022

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Opportunity (published 13 May 2022, last edited 8 June 2022)

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Contract summary

Industry

  • World wide web (www) site design services - 72413000

  • Marketing services - 79342000

  • Digital printing services - 79811000

    • Printing and distribution services - 79824000

    • Publishing services - 79970000

Location of contract

E14 4PU

Value of contract

£0.01

Procurement reference

CF-0828500D0O000000rwimUAA2

Published date

13 May 2022

Closing date

17 June 2022

Closing time

12pm

Contract start date

1 September 2022

Contract end date

31 December 2028

Contract type

Service contract

Procedure type

Other

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

The Medicines and Healthcare products Regulatory Agency (the Agency) is an Executive Agency of the Department of Health. We protect and improve the health of millions of people every day through the effective regulation of medicines and medical devices, underpinned by science and research.

The British Pharmacopoeia (BP) is the official collection of standards for UK medicinal products and pharmaceutical substances. It is produced by the British Pharmacopoeia Commission Secretariat of the Medicines and Healthcare Products Regulatory Agency, in accordance with regulation 317(1) of the Human Medicines Regulations 2012, and makes an important contribution to public health by setting publicly available standards for the quality of medicines.

The Agency requires the appointment of a Concessionaire to be responsible for the printing, publishing, distribution, marketing and selling of the BP and BAN publications.

For Suppliers to participate in the tender exercise for the Concession for Printing and Marketing of the British Pharmacopoeia contract they are required to download a Non Disclosure Agreement (NDA), sign the document and return.

Upon receipt of the signed NDA the Supplier shall be added to the Concession for Printing and Marketing of the British Pharmacopoeia ITT with full access to tender docs.

Please go onto our e-procurement portal Atamis (https://health-family.force.com/s/Welcome) to register and access the NDA document ref C67415.

More information

Previous notice about this procurement

Concession for Printing and Marketing of the British Pharmacopoeia

  • Opportunity
  • Published 13 May 2022

About the buyer

Contact name

Alison Finn

Address

10 South Colonnade
London
E14 4PU
GB

Email

alison.finn@nibsc.org